Paolo Gisondi to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications Paolo Gisondi has written about Biosimilar Pharmaceuticals.
Connection Strength
0.550
-
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry. Br J Dermatol. 2017 12; 177(6):e325-e326.
Score: 0.550
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.